Metzger-Peter K, Kremer LD, Edan G, Loureiro De Sousa P, Lamy J, Bagnard D, Mensah-Nyagan AG, Tricard T, Mathey G, Debouverie M, Berger E, Kerbrat A, Meyer N, De Seze J, Collongues N

Trials. 2020 Jun 29;21(1):591

Prediction of Drug Efficacy in Colon Cancer Preclinical Models Using a Novel Ranking Method of Gene Expression.

Fritz J, Lefebvre O, Fernandez A, Schmidt J, Bagnard D

Cancers (Basel). 2020 Jan 8;12(1):

Transmembrane Peptides as a New Strategy to Inhibit Neuraminidase-1 Activation.

Albrecht C, Kuznetsov AS, Appert-Collin A, Dhaideh Z, Callewaert M, Bershatsky YV, Urban AS, Bocharov EV, Bagnard D, Baud S, Blaise S, Romier-Crouzet B, Efremov RG, Dauchez M, Duca L, Gueroult M, Maurice P, Bennasroune A

Front Cell Dev Biol. 2020 ;8:611121

Transmembrane Peptides as Inhibitors of Protein-Protein Interactions: An Efficient Strategy to Target Cancer Cells?

Albrecht C, Appert-Collin A, Bagnard D, Blaise S, Romier-Crouzet B, Efremov RG, Sartelet H, Duca L, Maurice P, Bennasroune A

Front Oncol. 2020 ;10:519

Functionalized Coat Protein Monomers and Oligomers as Nanocarriers for Anti-Cancer Peptides.

Gamper C, Spenlé C, Boscá S, van der Heyden M, Erhardt M, Orend G, Bagnard D, Heinlein M

Cancers (Basel). 2019 Oct 22;11(10):

Disruption of Sema3A/Plexin-A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination.

Binamé F, Pham-Van LD, Spenlé C, Jolivel V, Birmpili D, Meyer LA, Jacob L, Meyer L, Mensah-Nyagan AG, Po C, Van der Heyden M, Roussel G, Bagnard D

EMBO Mol Med. 2019 Sep 30;:e10378

PREDMED®, a normalized expression signature of drug targets versus reference tissues aiming at generalizing treatment personalization.

Verlingue L, Baranger M, Gianesini C, Fritz J, Schaeffer M, Malka D, Jouffroy C, Loubaton B, Bagnard D

Ann. Oncol.. 2018 Sep;29 Suppl 6:vi9

Co-delivery of anti-PLK-1 siRNA and camptothecin by nanometric polydiacetylenic micelles results in a synergistic cell killing.

Ripoll M, Pierdant M, Neuberg P, Bagnard D, Wagner A, Kichler A, Remy JS

RSC Adv. 2018 Jun 5;8(37):20758-20763

Semaphorin 3A receptor inhibitor as a novel therapeutic to promote innervation of bioengineered teeth.

Kuchler-Bopp S, Bagnard D, Van-Der-Heyden M, Idoux-Gillet Y, Strub M, Gegout H, Lesot H, Benkirane-Jessel N, Keller L

J Tissue Eng Regen Med. 2018 Apr;12(4):e2151-e2161

PREDMED® TEST, new normalized expression method to predict the effect of tumor- and microenvironment-targeted therapies.

Fritz J, Verlingue L, Schmidt J, Baranger M, Gianesini C, Schaeffer M, Malka D, Scoazec JY, Loubaton B, Bagnard D

Ann. Oncol.. 2017 Oct;28 Suppl 7:vii5

Analysis of Semaphorin-Induced Growth Cone Collapse and Axon Growth Inhibition.

Meyer LA, Kaselis A, Satkauskas S, Bagnard D

Methods Mol. Biol.. 2017 ;1493:171-183

Current drug design to target the Semaphorin/Neuropilin/Plexin complexes.

Meyer LA, Fritz J, Pierdant-Mancera M, Bagnard D

Cell Adh Migr. 2016 Nov;10(6):700-708

Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide.

Jacob L, Sawma P, Garnier N, Meyer LA, Fritz J, Hussenet T, Spenlé C, Goetz J, Vermot J, Fernandez A, Baumlin N, Aci-Sèche S, Orend G, Roussel G, Crémel G, Genest M, Hubert P, Bagnard D

Oncotarget. 2016 09;7(36):57851-57865

Inhibition of primary breast tumor growth and metastasis using a neuropilin-1 transmembrane domain interfering peptide.

Arpel A, Gamper C, Spenlé C, Fernandez A, Jacob L, Baumlin N, Laquerriere P, Orend G, Crémel G, Bagnard D

Oncotarget. 2016 Aug;7(34):54723-54732

Spiro Di-orthoester (SpiDo), a Human Plasma Stable Acid-Sensitive Cleavable Linker for Lysosomal Release.

Leriche G, Nothisen M, Baumlin N, Muller CD, Bagnard D, Remy JS, Jacques SA, Wagner A

Bioconjug Chem. 2015 Jul 1.

Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.

Zeniou M, Feve M, Mameri S, Dong J, Salome C, Chen W, El-Habr EA, Bousson F, Sy M, Obszynski J, Boh A, Villa P, Assad Kahn S, Didier B, Bagnard D, Junier MP, Chneiweiss H, Haiech J, Hibert M, Kilhoffer MC

PLoS One. 2015 Aug 13;10(8):e0134793

Evidence for new homotypic and heterotypic interactions between transmembrane helices of proteins involved in receptor tyrosine kinase and neuropilin signaling.

Sawma P, Roth L, Blanchard C, Bagnard D, Cremel G, Bouveret E, Duneau JP, Sturgis JN, Hubert P

J Mol Biol. 2014 Dec 12;426(24):4099-111

In vivo characterization of the biodistribution profile of amphipol A8-35.

Fernandez A, Le Bon C, Baumlin N, Giusti F, Cremel G, Popot JL, Bagnard D

J Membr Biol. 2014 Oct;247(9-10):1043-51

Transmembrane domain targeting peptide antagonizing ErbB2/Neu inhibits breast tumor growth and metastasis.

Arpel A, Sawma P, Spenle C, Fritz J, Meyer L, Garnier N, Velazquez-Quesada I, Hussenet T, Aci-Seche S, Baumlin N, Genest M, Brasse D, Hubert P, Cremel G, Orend G, Laquerriere P, Bagnard D

Cell Rep. 2014 Sep 25;8(6):1714-21

Amyloid precursor protein at node of Ranvier modulates nodal formation.

Xu DE, Zhang WM, Yang ZZ, Zhu HM, Yan K, Li S, Bagnard D, Dawe GS, Ma QH, Xiao ZC

Cell Adh Migr. 2014 Apr 11;8(4).

Amyloid precursor protein at node of Ranvier modulates nodal formation.

Xu DE, Zhang WM, Yang ZZ, Zhu HM, Yan K, Li S, Bagnard D, Dawe GS, Ma QH, Xiao ZC

Cell Adh Migr. 2014;8(4):396-403

R-Type Calcium Channels Are Crucial for Semaphorin 3A-Induced DRG Axon Growth Cone Collapse.

Treinys R, Kaselis A, Jover E, Bagnard D, Satkauskas S

PLoS One. 2014 Jul 17;9(7):e102357

Transmembrane recognition of the semaphorin co-receptors neuropilin 1 and plexin A1: coarse-grained simulations.

Aci-Seche S, Sawma P, Hubert P, Sturgis JN, Bagnard D, Jacob L, Genest M, Garnier N

PLoS One. 2014 May 23;9(5):e97779

Integration of opposing semaphorin guidance cues in cortical axons.

Ruediger T, Zimmer G, Barchmann S, Castellani V, Bagnard D, Bolz J

Cereb Cortex. 2013 Mar;23(3):604-14

Abnormal Wnt and PI3Kinase signaling in the malformed intestine of lama5 deficient mice.

Ritie L, Spenle C, Lacroute J, Bolcato-Bellemin AL, Lefebvre O, Bole-Feysot C, Jost B, Klein A, Arnold C, Kedinger M, Bagnard D, Orend G, Simon-Assmann P

PLoS One. 2012;7(5):e37710

Functional role of laminin alpha1 chain during cerebellum development.

Heng C, Lefebvre O, Klein A, Edwards MM, Simon-Assmann P, Orend G, Bagnard D

Cell Adh Migr. 2011 Nov-Dec;5(6):480-9.

Amphipols from A to Z.

Popot JL, Althoff T, Bagnard D, Baneres JL, Bazzacco P, Billon-Denis E, Catoire LJ, Champeil P, Charvolin D, Cocco MJ, Cremel G, Dahmane T, de la Maza LM, Ebel C, Gabel F, Giusti F, Gohon Y, Goormaghtigh E, Guittet E, Kleinschmidt JH, Kuhlbrandt W, Le Bon C, Martinez KL, Picard M, Pucci B, Sachs JN, Tribet C, van Heijenoort C, Wien F, Zito F, Zoonens M

Annu Rev Biophys. 2011 Jun 9;40:379-408.

A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins.

Destouches D, Page N, Hamma-Kourbali Y, Machi V, Chaloin O, Frechault S, Birmpas C, Katsoris P, Beyrath J, Albanese P, Maurer M, Carpentier G, Strub JM, Van Dorsselaer A, Muller S, Bagnard D, Briand JP, Courty J

Cancer Res. 2011 May 1;71(9):3296-305

HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus.

Page N, Gros F, Schall N, Decossas M, Bagnard D, Briand JP, Muller S

Ann Rheum Dis. 2011 May;70(5):837-43

Solid-phase synthesis of quinol fatty alcohols, design of N/O-substituted quinol fatty alcohols and comparative activities on axonal growth.

Hanbali M, Bagnard D, Luu B

Bioorg Med Chem Lett. 2006 Aug 1;16(15):3917-20

Quinol fatty alcohols as promoters of axonal growth.

Hanbali M, Vela-Ruiz M, Bagnard D, Luu B

Bioorg Med Chem Lett. 2006 May 15;16(10):2637-40

Membrane-associated guidance cues direct the innervation of forebrain and midbrain by dorsal raphe-derived serotonergic axons.

Petit A, Kennedy TE, Bagnard D, Doucet G

Eur J Neurosci. 2005 Aug;22(3):552-68.